aluates Reports

$ 0.0

Automative

Global Nanotechnology-based Drug Delivery Systems Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-1B15789

Global Nanotechnology based Drug Delivery Systems Market Research Report 2023

BUY CHAPTERS

Global Nanotechnology-based Drug Delivery Systems Market Research Report 2025

Code: QYRE-Auto-1B15789

Report

May 2025

Pages:99

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Johnson & Johnson

Sun Pharmaceutical

CSPC

Kinyond

TEVA

Fudan-Zhangjiang

Zydus Cadila

TTY Biopharma

Pacira

Luye Pharma

Leadiant Biosciences

Ipsen S A

Sayre Therapeutics

JAZZ

Alnylam

Bausch Health

Acrotech Biopharma

Takeda

Chiesi Farmaceutici

Gilead Sciences

Nanotechnology-based Drug Delivery Systems Market Size

The global market for Nanotechnology-based Drug Delivery Systems was valued at US$ 6065 million in the year 2024 and is projected to reach a revised size of US$ 11710 million by 2031, growing at a CAGR of 10.0% during the forecast period.

Nanotechnology-based Drug Delivery Systems Market

Nanoparticle drug delivery systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side-effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential application for effective drug delivery.

The Nano-based Drug Delivery System Market is driven by the demand for more effective and targeted drug delivery methods. Nano-based systems offer improved drug solubility, bioavailability, and reduced side effects. However, a significant challenge is the complexity of nanotechnology and the need for rigorous safety assessments and regulatory approvals. Ensuring the safety and biocompatibility of nano-based drug delivery systems is crucial. Additionally, competition in the market and cost considerations pose challenges, necessitating a balance between affordability and the development of advanced nano-based drug delivery technologies to meet the evolving needs of the pharmaceutical industry while ensuring patient well-being.

This report aims to provide a comprehensive presentation of the global market for Nanotechnology-based Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanotechnology-based Drug Delivery Systems.

The Nanotechnology-based Drug Delivery Systems market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nanotechnology-based Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nanotechnology-based Drug Delivery Systems companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Nanotechnology-based Drug Delivery Systems Market Report

Report Metric	Details
Report Name	Nanotechnology-based Drug Delivery Systems Market
Accounted market size in year	US$ 6065 million
Forecasted market size in 2031	US$ 11710 million
CAGR	10.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Liposomes Drugs Lipid Nanoparticle Drugs
Segment by Application	Hospital Retail Pharmacy Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Johnson & Johnson, Sun Pharmaceutical, CSPC, Kinyond, Teva, Fudan-Zhangjiang, Zydus Cadila, TTY Biopharma, Pacira, Luye Pharma, Leadiant Biosciences, Ipsen, Sayre Therapeutics, Jazz, Alnylam, Bausch Health, Acrotech Biopharma, Takeda, Chiesi Farmaceutici, Gilead Sciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nanotechnology-based Drug Delivery Systems company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Nanotechnology-based Drug Delivery Systems Market growing?

Ans: The Nanotechnology-based Drug Delivery Systems Market witnessing a CAGR of 10.0% during the forecast period 2025-2031.

What is the Nanotechnology-based Drug Delivery Systems Market size in 2031?

Ans: The Nanotechnology-based Drug Delivery Systems Market size in 2031 will be US$ 11710 million.

Who are the main players in the Nanotechnology-based Drug Delivery Systems Market report?

Ans: The main players in the Nanotechnology-based Drug Delivery Systems Market are Johnson & Johnson, Sun Pharmaceutical, CSPC, Kinyond, Teva, Fudan-Zhangjiang, Zydus Cadila, TTY Biopharma, Pacira, Luye Pharma, Leadiant Biosciences, Ipsen, Sayre Therapeutics, Jazz, Alnylam, Bausch Health, Acrotech Biopharma, Takeda, Chiesi Farmaceutici, Gilead Sciences

What are the Application segmentation covered in the Nanotechnology-based Drug Delivery Systems Market report?

Ans: The Applications covered in the Nanotechnology-based Drug Delivery Systems Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the Nanotechnology-based Drug Delivery Systems Market report?

Ans: The Types covered in the Nanotechnology-based Drug Delivery Systems Market report are Liposomes Drugs, Lipid Nanoparticle Drugs

Recommended Reports

Drug Delivery Systems

Nanotechnology Medicine

Nano Drug Delivery

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Nanotechnology-based Drug Delivery Systems Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Liposomes Drugs

1.2.3 Lipid Nanoparticle Drugs

1.3 Market by Application

1.3.1 Global Nanotechnology-based Drug Delivery Systems Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Retail Pharmacy

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Nanotechnology-based Drug Delivery Systems Market Perspective (2020-2031)

2.2 Global Nanotechnology-based Drug Delivery Systems Growth Trends by Region

2.2.1 Global Nanotechnology-based Drug Delivery Systems Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Nanotechnology-based Drug Delivery Systems Historic Market Size by Region (2020-2025)

2.2.3 Nanotechnology-based Drug Delivery Systems Forecasted Market Size by Region (2026-2031)

2.3 Nanotechnology-based Drug Delivery Systems Market Dynamics

2.3.1 Nanotechnology-based Drug Delivery Systems Industry Trends

2.3.2 Nanotechnology-based Drug Delivery Systems Market Drivers

2.3.3 Nanotechnology-based Drug Delivery Systems Market Challenges

2.3.4 Nanotechnology-based Drug Delivery Systems Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Nanotechnology-based Drug Delivery Systems Players by Revenue

3.1.1 Global Top Nanotechnology-based Drug Delivery Systems Players by Revenue (2020-2025)

3.1.2 Global Nanotechnology-based Drug Delivery Systems Revenue Market Share by Players (2020-2025)

3.2 Global Nanotechnology-based Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Nanotechnology-based Drug Delivery Systems Revenue

3.4 Global Nanotechnology-based Drug Delivery Systems Market Concentration Ratio

3.4.1 Global Nanotechnology-based Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Nanotechnology-based Drug Delivery Systems Revenue in 2024

3.5 Global Key Players of Nanotechnology-based Drug Delivery Systems Head office and Area Served

3.6 Global Key Players of Nanotechnology-based Drug Delivery Systems, Product and Application

3.7 Global Key Players of Nanotechnology-based Drug Delivery Systems, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Nanotechnology-based Drug Delivery Systems Breakdown Data by Type

4.1 Global Nanotechnology-based Drug Delivery Systems Historic Market Size by Type (2020-2025)

4.2 Global Nanotechnology-based Drug Delivery Systems Forecasted Market Size by Type (2026-2031)

5 Nanotechnology-based Drug Delivery Systems Breakdown Data by Application

5.1 Global Nanotechnology-based Drug Delivery Systems Historic Market Size by Application (2020-2025)

5.2 Global Nanotechnology-based Drug Delivery Systems Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Nanotechnology-based Drug Delivery Systems Market Size (2020-2031)

6.2 North America Nanotechnology-based Drug Delivery Systems Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Nanotechnology-based Drug Delivery Systems Market Size by Country (2020-2025)

6.4 North America Nanotechnology-based Drug Delivery Systems Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Nanotechnology-based Drug Delivery Systems Market Size (2020-2031)

7.2 Europe Nanotechnology-based Drug Delivery Systems Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Nanotechnology-based Drug Delivery Systems Market Size by Country (2020-2025)

7.4 Europe Nanotechnology-based Drug Delivery Systems Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Nanotechnology-based Drug Delivery Systems Market Size (2020-2031)

8.2 Asia-Pacific Nanotechnology-based Drug Delivery Systems Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Nanotechnology-based Drug Delivery Systems Market Size by Region (2020-2025)

8.4 Asia-Pacific Nanotechnology-based Drug Delivery Systems Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Nanotechnology-based Drug Delivery Systems Market Size (2020-2031)

9.2 Latin America Nanotechnology-based Drug Delivery Systems Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Nanotechnology-based Drug Delivery Systems Market Size by Country (2020-2025)

9.4 Latin America Nanotechnology-based Drug Delivery Systems Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Nanotechnology-based Drug Delivery Systems Market Size (2020-2031)

10.2 Middle East & Africa Nanotechnology-based Drug Delivery Systems Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Nanotechnology-based Drug Delivery Systems Market Size by Country (2020-2025)

10.4 Middle East & Africa Nanotechnology-based Drug Delivery Systems Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Johnson & Johnson

11.1.1 Johnson & Johnson Company Details

11.1.2 Johnson & Johnson Business Overview

11.1.3 Johnson & Johnson Nanotechnology-based Drug Delivery Systems Introduction

11.1.4 Johnson & Johnson Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

11.1.5 Johnson & Johnson Recent Development

11.2 Sun Pharmaceutical

11.2.1 Sun Pharmaceutical Company Details

11.2.2 Sun Pharmaceutical Business Overview

11.2.3 Sun Pharmaceutical Nanotechnology-based Drug Delivery Systems Introduction

11.2.4 Sun Pharmaceutical Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

11.2.5 Sun Pharmaceutical Recent Development

11.3 CSPC

11.3.1 CSPC Company Details

11.3.2 CSPC Business Overview

11.3.3 CSPC Nanotechnology-based Drug Delivery Systems Introduction

11.3.4 CSPC Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

11.3.5 CSPC Recent Development

11.4 Kinyond

11.4.1 Kinyond Company Details

11.4.2 Kinyond Business Overview

11.4.3 Kinyond Nanotechnology-based Drug Delivery Systems Introduction

11.4.4 Kinyond Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

11.4.5 Kinyond Recent Development

11.5 Teva

11.5.1 Teva Company Details

11.5.2 Teva Business Overview

11.5.3 Teva Nanotechnology-based Drug Delivery Systems Introduction

11.5.4 Teva Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

11.5.5 Teva Recent Development

11.6 Fudan-Zhangjiang

11.6.1 Fudan-Zhangjiang Company Details

11.6.2 Fudan-Zhangjiang Business Overview

11.6.3 Fudan-Zhangjiang Nanotechnology-based Drug Delivery Systems Introduction

11.6.4 Fudan-Zhangjiang Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

11.6.5 Fudan-Zhangjiang Recent Development

11.7 Zydus Cadila

11.7.1 Zydus Cadila Company Details

11.7.2 Zydus Cadila Business Overview

11.7.3 Zydus Cadila Nanotechnology-based Drug Delivery Systems Introduction

11.7.4 Zydus Cadila Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

11.7.5 Zydus Cadila Recent Development

11.8 TTY Biopharma

11.8.1 TTY Biopharma Company Details

11.8.2 TTY Biopharma Business Overview

11.8.3 TTY Biopharma Nanotechnology-based Drug Delivery Systems Introduction

11.8.4 TTY Biopharma Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

11.8.5 TTY Biopharma Recent Development

11.9 Pacira

11.9.1 Pacira Company Details

11.9.2 Pacira Business Overview

11.9.3 Pacira Nanotechnology-based Drug Delivery Systems Introduction

11.9.4 Pacira Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

11.9.5 Pacira Recent Development

11.10 Luye Pharma

11.10.1 Luye Pharma Company Details

11.10.2 Luye Pharma Business Overview

11.10.3 Luye Pharma Nanotechnology-based Drug Delivery Systems Introduction

11.10.4 Luye Pharma Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

11.10.5 Luye Pharma Recent Development

11.11 Leadiant Biosciences

11.11.1 Leadiant Biosciences Company Details

11.11.2 Leadiant Biosciences Business Overview

11.11.3 Leadiant Biosciences Nanotechnology-based Drug Delivery Systems Introduction

11.11.4 Leadiant Biosciences Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

11.11.5 Leadiant Biosciences Recent Development

11.12 Ipsen

11.12.1 Ipsen Company Details

11.12.2 Ipsen Business Overview

11.12.3 Ipsen Nanotechnology-based Drug Delivery Systems Introduction

11.12.4 Ipsen Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

11.12.5 Ipsen Recent Development

11.13 Sayre Therapeutics

11.13.1 Sayre Therapeutics Company Details

11.13.2 Sayre Therapeutics Business Overview

11.13.3 Sayre Therapeutics Nanotechnology-based Drug Delivery Systems Introduction

11.13.4 Sayre Therapeutics Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

11.13.5 Sayre Therapeutics Recent Development

11.14 Jazz

11.14.1 Jazz Company Details

11.14.2 Jazz Business Overview

11.14.3 Jazz Nanotechnology-based Drug Delivery Systems Introduction

11.14.4 Jazz Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

11.14.5 Jazz Recent Development

11.15 Alnylam

11.15.1 Alnylam Company Details

11.15.2 Alnylam Business Overview

11.15.3 Alnylam Nanotechnology-based Drug Delivery Systems Introduction

11.15.4 Alnylam Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

11.15.5 Alnylam Recent Development

11.16 Bausch Health

11.16.1 Bausch Health Company Details

11.16.2 Bausch Health Business Overview

11.16.3 Bausch Health Nanotechnology-based Drug Delivery Systems Introduction

11.16.4 Bausch Health Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

11.16.5 Bausch Health Recent Development

11.17 Acrotech Biopharma

11.17.1 Acrotech Biopharma Company Details

11.17.2 Acrotech Biopharma Business Overview

11.17.3 Acrotech Biopharma Nanotechnology-based Drug Delivery Systems Introduction

11.17.4 Acrotech Biopharma Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

11.17.5 Acrotech Biopharma Recent Development

11.18 Takeda

11.18.1 Takeda Company Details

11.18.2 Takeda Business Overview

11.18.3 Takeda Nanotechnology-based Drug Delivery Systems Introduction

11.18.4 Takeda Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

11.18.5 Takeda Recent Development

11.19 Chiesi Farmaceutici

11.19.1 Chiesi Farmaceutici Company Details

11.19.2 Chiesi Farmaceutici Business Overview

11.19.3 Chiesi Farmaceutici Nanotechnology-based Drug Delivery Systems Introduction

11.19.4 Chiesi Farmaceutici Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

11.19.5 Chiesi Farmaceutici Recent Development

11.20 Gilead Sciences

11.20.1 Gilead Sciences Company Details

11.20.2 Gilead Sciences Business Overview

11.20.3 Gilead Sciences Nanotechnology-based Drug Delivery Systems Introduction

11.20.4 Gilead Sciences Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

11.20.5 Gilead Sciences Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Johnson & Johnson

Sun Pharmaceutical

CSPC

Kinyond

TEVA

Fudan-Zhangjiang

Zydus Cadila

TTY Biopharma

Pacira

Luye Pharma

Leadiant Biosciences

Ipsen S A

Sayre Therapeutics

JAZZ

Alnylam

Bausch Health

Acrotech Biopharma

Takeda

Chiesi Farmaceutici

Gilead Sciences

List of Tables

Table 1. Global Nanotechnology-based Drug Delivery Systems Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Liposomes Drugs

Table 3. Key Players of Lipid Nanoparticle Drugs

Table 4. Global Nanotechnology-based Drug Delivery Systems Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Nanotechnology-based Drug Delivery Systems Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Nanotechnology-based Drug Delivery Systems Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Nanotechnology-based Drug Delivery Systems Market Share by Region (2020-2025)

Table 8. Global Nanotechnology-based Drug Delivery Systems Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Nanotechnology-based Drug Delivery Systems Market Share by Region (2026-2031)

Table 10. Nanotechnology-based Drug Delivery Systems Market Trends

Table 11. Nanotechnology-based Drug Delivery Systems Market Drivers

Table 12. Nanotechnology-based Drug Delivery Systems Market Challenges

Table 13. Nanotechnology-based Drug Delivery Systems Market Restraints

Table 14. Global Nanotechnology-based Drug Delivery Systems Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Nanotechnology-based Drug Delivery Systems Market Share by Players (2020-2025)

Table 16. Global Top Nanotechnology-based Drug Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanotechnology-based Drug Delivery Systems as of 2024)

Table 17. Ranking of Global Top Nanotechnology-based Drug Delivery Systems Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Nanotechnology-based Drug Delivery Systems Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Nanotechnology-based Drug Delivery Systems, Headquarters and Area Served

Table 20. Global Key Players of Nanotechnology-based Drug Delivery Systems, Product and Application

Table 21. Global Key Players of Nanotechnology-based Drug Delivery Systems, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Nanotechnology-based Drug Delivery Systems Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Nanotechnology-based Drug Delivery Systems Revenue Market Share by Type (2020-2025)

Table 25. Global Nanotechnology-based Drug Delivery Systems Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Nanotechnology-based Drug Delivery Systems Revenue Market Share by Type (2026-2031)

Table 27. Global Nanotechnology-based Drug Delivery Systems Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Nanotechnology-based Drug Delivery Systems Revenue Market Share by Application (2020-2025)

Table 29. Global Nanotechnology-based Drug Delivery Systems Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Nanotechnology-based Drug Delivery Systems Revenue Market Share by Application (2026-2031)

Table 31. North America Nanotechnology-based Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Nanotechnology-based Drug Delivery Systems Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Nanotechnology-based Drug Delivery Systems Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Nanotechnology-based Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Nanotechnology-based Drug Delivery Systems Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Nanotechnology-based Drug Delivery Systems Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Nanotechnology-based Drug Delivery Systems Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Nanotechnology-based Drug Delivery Systems Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Nanotechnology-based Drug Delivery Systems Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Nanotechnology-based Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Nanotechnology-based Drug Delivery Systems Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Nanotechnology-based Drug Delivery Systems Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Nanotechnology-based Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Nanotechnology-based Drug Delivery Systems Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Nanotechnology-based Drug Delivery Systems Market Size by Country (2026-2031) & (US$ Million)

Table 46. Johnson & Johnson Company Details

Table 47. Johnson & Johnson Business Overview

Table 48. Johnson & Johnson Nanotechnology-based Drug Delivery Systems Product

Table 49. Johnson & Johnson Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 50. Johnson & Johnson Recent Development

Table 51. Sun Pharmaceutical Company Details

Table 52. Sun Pharmaceutical Business Overview

Table 53. Sun Pharmaceutical Nanotechnology-based Drug Delivery Systems Product

Table 54. Sun Pharmaceutical Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 55. Sun Pharmaceutical Recent Development

Table 56. CSPC Company Details

Table 57. CSPC Business Overview

Table 58. CSPC Nanotechnology-based Drug Delivery Systems Product

Table 59. CSPC Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 60. CSPC Recent Development

Table 61. Kinyond Company Details

Table 62. Kinyond Business Overview

Table 63. Kinyond Nanotechnology-based Drug Delivery Systems Product

Table 64. Kinyond Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 65. Kinyond Recent Development

Table 66. Teva Company Details

Table 67. Teva Business Overview

Table 68. Teva Nanotechnology-based Drug Delivery Systems Product

Table 69. Teva Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 70. Teva Recent Development

Table 71. Fudan-Zhangjiang Company Details

Table 72. Fudan-Zhangjiang Business Overview

Table 73. Fudan-Zhangjiang Nanotechnology-based Drug Delivery Systems Product

Table 74. Fudan-Zhangjiang Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 75. Fudan-Zhangjiang Recent Development

Table 76. Zydus Cadila Company Details

Table 77. Zydus Cadila Business Overview

Table 78. Zydus Cadila Nanotechnology-based Drug Delivery Systems Product

Table 79. Zydus Cadila Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 80. Zydus Cadila Recent Development

Table 81. TTY Biopharma Company Details

Table 82. TTY Biopharma Business Overview

Table 83. TTY Biopharma Nanotechnology-based Drug Delivery Systems Product

Table 84. TTY Biopharma Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 85. TTY Biopharma Recent Development

Table 86. Pacira Company Details

Table 87. Pacira Business Overview

Table 88. Pacira Nanotechnology-based Drug Delivery Systems Product

Table 89. Pacira Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 90. Pacira Recent Development

Table 91. Luye Pharma Company Details

Table 92. Luye Pharma Business Overview

Table 93. Luye Pharma Nanotechnology-based Drug Delivery Systems Product

Table 94. Luye Pharma Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 95. Luye Pharma Recent Development

Table 96. Leadiant Biosciences Company Details

Table 97. Leadiant Biosciences Business Overview

Table 98. Leadiant Biosciences Nanotechnology-based Drug Delivery Systems Product

Table 99. Leadiant Biosciences Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 100. Leadiant Biosciences Recent Development

Table 101. Ipsen Company Details

Table 102. Ipsen Business Overview

Table 103. Ipsen Nanotechnology-based Drug Delivery Systems Product

Table 104. Ipsen Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 105. Ipsen Recent Development

Table 106. Sayre Therapeutics Company Details

Table 107. Sayre Therapeutics Business Overview

Table 108. Sayre Therapeutics Nanotechnology-based Drug Delivery Systems Product

Table 109. Sayre Therapeutics Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 110. Sayre Therapeutics Recent Development

Table 111. Jazz Company Details

Table 112. Jazz Business Overview

Table 113. Jazz Nanotechnology-based Drug Delivery Systems Product

Table 114. Jazz Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 115. Jazz Recent Development

Table 116. Alnylam Company Details

Table 117. Alnylam Business Overview

Table 118. Alnylam Nanotechnology-based Drug Delivery Systems Product

Table 119. Alnylam Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 120. Alnylam Recent Development

Table 121. Bausch Health Company Details

Table 122. Bausch Health Business Overview

Table 123. Bausch Health Nanotechnology-based Drug Delivery Systems Product

Table 124. Bausch Health Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 125. Bausch Health Recent Development

Table 126. Acrotech Biopharma Company Details

Table 127. Acrotech Biopharma Business Overview

Table 128. Acrotech Biopharma Nanotechnology-based Drug Delivery Systems Product

Table 129. Acrotech Biopharma Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 130. Acrotech Biopharma Recent Development

Table 131. Takeda Company Details

Table 132. Takeda Business Overview

Table 133. Takeda Nanotechnology-based Drug Delivery Systems Product

Table 134. Takeda Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 135. Takeda Recent Development

Table 136. Chiesi Farmaceutici Company Details

Table 137. Chiesi Farmaceutici Business Overview

Table 138. Chiesi Farmaceutici Nanotechnology-based Drug Delivery Systems Product

Table 139. Chiesi Farmaceutici Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 140. Chiesi Farmaceutici Recent Development

Table 141. Gilead Sciences Company Details

Table 142. Gilead Sciences Business Overview

Table 143. Gilead Sciences Nanotechnology-based Drug Delivery Systems Product

Table 144. Gilead Sciences Revenue in Nanotechnology-based Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 145. Gilead Sciences Recent Development

Table 146. Research Programs/Design for This Report

Table 147. Key Data Information from Secondary Sources

Table 148. Key Data Information from Primary Sources

Table 149. Authors List of This Report

List of Figures

Figure 1. Nanotechnology-based Drug Delivery Systems Picture

Figure 2. Global Nanotechnology-based Drug Delivery Systems Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Nanotechnology-based Drug Delivery Systems Market Share by Type: 2024 VS 2031

Figure 4. Liposomes Drugs Features

Figure 5. Lipid Nanoparticle Drugs Features

Figure 6. Global Nanotechnology-based Drug Delivery Systems Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Nanotechnology-based Drug Delivery Systems Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Retail Pharmacy Case Studies

Figure 10. Other Case Studies

Figure 11. Nanotechnology-based Drug Delivery Systems Report Years Considered

Figure 12. Global Nanotechnology-based Drug Delivery Systems Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Nanotechnology-based Drug Delivery Systems Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Nanotechnology-based Drug Delivery Systems Market Share by Region: 2024 VS 2031

Figure 15. Global Nanotechnology-based Drug Delivery Systems Market Share by Players in 2024

Figure 16. Global Top Nanotechnology-based Drug Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanotechnology-based Drug Delivery Systems as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Nanotechnology-based Drug Delivery Systems Revenue in 2024

Figure 18. North America Nanotechnology-based Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Nanotechnology-based Drug Delivery Systems Market Share by Country (2020-2031)

Figure 20. United States Nanotechnology-based Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Nanotechnology-based Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Nanotechnology-based Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Nanotechnology-based Drug Delivery Systems Market Share by Country (2020-2031)

Figure 24. Germany Nanotechnology-based Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Nanotechnology-based Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Nanotechnology-based Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Nanotechnology-based Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Nanotechnology-based Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Nanotechnology-based Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Nanotechnology-based Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Nanotechnology-based Drug Delivery Systems Market Share by Region (2020-2031)

Figure 32. China Nanotechnology-based Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Nanotechnology-based Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Nanotechnology-based Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Nanotechnology-based Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Nanotechnology-based Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Nanotechnology-based Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Nanotechnology-based Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Nanotechnology-based Drug Delivery Systems Market Share by Country (2020-2031)

Figure 40. Mexico Nanotechnology-based Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Nanotechnology-based Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Nanotechnology-based Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Nanotechnology-based Drug Delivery Systems Market Share by Country (2020-2031)

Figure 44. Turkey Nanotechnology-based Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Nanotechnology-based Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Nanotechnology-based Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Johnson & Johnson Revenue Growth Rate in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

Figure 48. Sun Pharmaceutical Revenue Growth Rate in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

Figure 49. CSPC Revenue Growth Rate in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

Figure 50. Kinyond Revenue Growth Rate in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

Figure 51. Teva Revenue Growth Rate in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

Figure 52. Fudan-Zhangjiang Revenue Growth Rate in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

Figure 53. Zydus Cadila Revenue Growth Rate in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

Figure 54. TTY Biopharma Revenue Growth Rate in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

Figure 55. Pacira Revenue Growth Rate in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

Figure 56. Luye Pharma Revenue Growth Rate in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

Figure 57. Leadiant Biosciences Revenue Growth Rate in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

Figure 58. Ipsen Revenue Growth Rate in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

Figure 59. Sayre Therapeutics Revenue Growth Rate in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

Figure 60. Jazz Revenue Growth Rate in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

Figure 61. Alnylam Revenue Growth Rate in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

Figure 62. Bausch Health Revenue Growth Rate in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

Figure 63. Acrotech Biopharma Revenue Growth Rate in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

Figure 64. Takeda Revenue Growth Rate in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

Figure 65. Chiesi Farmaceutici Revenue Growth Rate in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

Figure 66. Gilead Sciences Revenue Growth Rate in Nanotechnology-based Drug Delivery Systems Business (2020-2025)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Nanotechnology in Targeted Drug Delivery Market Research Report 2024

Global Nanoparticle Mediated Delivery Market Research Report 2025

Liposomal based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Liposomes Nanoparticle Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Nanoparticle Drug Delivery System Market Research Report 2024

Liposome Finished Pharmaceuticals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Liposomal and Lipid Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Liposomal and Lipid based Nanoparticle Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Liposomes Nanocarrier Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Liposome and Lipid Nanoparticle Finished Pharmaceuticals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Liposome FDF Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Liposome and Lipid Nanoparticle FDF Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Targeted Drug Delivery System Market Research Report 2025

Global Nanomedicines Market Research Report 2024

Global Pharmaceutical Drug Delivery Technologies Market Insights Forecast to 2030

Global Nanoparticle Carriers Market Research Report 2024

Global Pharmaceutical Drug Delivery Devices Market Insights Forecast to 2030

Global Nanoparticle Drug Delivery Systems Market Research Report 2024

Global Targeted Drug Delivery Device Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions